Victor Dirda

Learn More
In two double-blind trials, volunteers challenged with rhinovirus were treated with aspirin or placebo. Aspirin treatment did not alter the rates of infection or illness but was associated with a moderate reduction in the frequency or severity of some symptoms. The overall benefit in rhinovirus infection was not statistically significant. Aspirin treatment(More)
This paper presents a bridging framework for combining the results of various models of human-computer interaction. It views a system as a composite of interacting subsystems, and describes how those subsystems must be structured to permit compositions in which responsibility for global behavior can be appropriately ascribed. The paper presents a(More)
Six controlled trials of a topical interferon inducer, N',N'-diotadecyl-N',N'-bis-(2-hydroxyethyl) propanediamine (CP 20961), against rhinovirus infection in volunteers were reviewed. Controls were the drug vehicle (which consisted of a mixture of polysorbate-80 in gylcerol and saline), saline only, and oral lactose. Multiple doses of the inducer given(More)
  • 1